Nina Chi Sabins

Title: **Nina Chi Sabins: Innovating in Immunotherapy**

Introduction

Nina Chi Sabins is an accomplished inventor based in Spring House, PA, known for her significant contributions to the field of immunotherapy. With a focus on innovative developments in antibody technology, Sabins has made strides that could impact treatments for various diseases.

Latest Patents

Nina holds two patents that highlight her expertise in the biomedical field. Her latest patents are titled "Antibodies Specifically Binding PD-1, TIM-3 or PD-1 and TIM-3 and Their Uses." These patents involve antibodies that specifically bind to PD-1 and TIM-3, two critical immune checkpoint proteins, alongside polynucleotides encoding these antibodies or their fragments. The methods outlined in her patents provide insights into creating and utilizing these antibodies in therapeutic applications.

Career Highlights

Nina currently works with Janssen Biotech, Inc., a subsidiary of Johnson & Johnson, where she engages in pioneering research that could transform treatment protocols for cancer and other immune-related conditions. Her roles involve both research and development, allowing her to harness her inventive skills to advance healthcare solutions.

Collaborations

During her career, Nina has collaborated with prominent colleagues including Gordon Powers and Nikki A DeAngelis. These partnerships have fostered a collaborative environment conducive to innovation, combining their expertise to further the development of groundbreaking therapies.

Conclusion

Nina Chi Sabins represents the new wave of inventors dedicated to improving medical science through innovative research and patent development. Her contributions to antibodies targeting PD-1 and TIM-3 exemplify her commitment to advancing healthcare, reinforcing the vital role inventors play in pioneering treatments that can save lives.